Studies of the hypoglycemic effect of D-amphetamine in aggregated mice.
D000409:Alanine / Q000378:metabolism; D000818:Animals; D000917:Antibody Formation; D001522:Behavior, Animal / Q000187:drug effects*; D001786:Blood Glucose / Q000032:analysis; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D003913:Dextroamphetamine / Q000494:pharmacology*; D005227:Fatty Acids / Q000032:analysis; D005947:Glucose / Q000378:metabolism; D007003:Hypoglycemia / Q000139:chemically induced*; D066298:In Vitro Techniques; D007328:Insulin / Q000032:analysis; D007330:Insulin Antibodies / Q000494:pharmacology; D007773:Lactates / Q000097:blood; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000032:analysis / Q000378:metabolism; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D051379:Mice; D010084:Oxidation-Reduction; D010179:Pancreas / Q000032:analysis
D001786:Blood Glucose; D002247:Carbon Isotopes; D005227:Fatty Acids; D007328:Insulin; D007330:Insulin Antibodies; D007773:Lactates; D008055:Lipids; D008112:Liver Glycogen; D002245:Carbon Dioxide; D005947:Glucose; D000409:Alanine; D003913:Dextroamphetamine